— Know what they know.
Not Investment Advice
Also trades as: 600196.SS (SHH) · $vol 96M · 2196.HK (HKSE) · $vol 9M

SFOSF OTC

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
1W: +11.4% 1M: +11.4% 3M: +21.3% YTD: -11.9% 1Y: -30.0% 3Y: +10.9% 5Y: -51.0%
$2.45
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 72 · $6.5B mcap · 941M float · 0.0000% daily turnover · Short 57% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$6.5B
52W Range1.93-3.31
Volume100
Avg Volume242
Beta0.44
Dividend$0.06
Analyst Ratings
No analyst coverage
Company Info
CEOYi Liu
Employees40,603
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2014-04-21
Building A
Shanghai, SH 200233
CN
86 21 3398 7000
About Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF), founded in 1994 and based in Shanghai, China, is a comprehensive pharmaceutical enterprise. The company is actively engaged in the research, development, manufacturing, and sale of pharmaceutical products, serving markets across Mainland China and internationally. Its diverse operations are structured into five main segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Services, Pharmaceutical Distribution and Retail, and Other Business activities. Within its pharmaceutical portfolio, Fosun Pharma focuses on critical therapeutic areas such as oncology, immune system modulation, metabolic disorders, gastrointestinal conditions, and central nervous system ailments. Beyond its drug offerings, the company also provides a range of medical equipment and diagnostic solutions. Furthermore, SFOSF is involved in delivering healthcare services and managing hospitals, alongside its wholesale and retail distribution of medicines.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms